Welcome to CDC stacks | Prior season vaccination and risk of influenza during the 2014–2015 season in the U.S - 49118 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prior season vaccination and risk of influenza during the 2014–2015 season in the U.S
  • Published Date:
    Jul 15 2017
  • Source:
    J Infect Dis. 216(2):284-285.
  • Language:
    English
Filetype[PDF-40.89 KB]


No Related Documents.
You May Also Like:
  1. An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children
    Personal Author:
    Florek, Nicholas W.; Campos, Luiza M.; Braun, Katarina M.; McLean, Huong Q.; King, Jennifer P.; Flannery, Brendan; Belongia, Edward A.; Friedrich, Thomas C.;
    Published:
    Dec 15 2017
    Source:
    Vaccine. 36(5):758-764
    Description:
    Background : Influenza vaccination may provide a “back-boost” to antibodies against previously encountered strains. If the back-boost effect is common, this could allow more aggressive vaccine updates, as emerging variants would be expected to bo...
    File Type:
    Filetype[PDF - 507.69 KB]
  2. Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type
    Personal Author:
    McLean, Huong Q.; Thompson, Mark G.; Sundaram, Maria E.; Kieke, Burney A.; Gaglani, Manjusha; Murthy, Kempapura; Piedra, Pedro A.; Zimmerman, Richard K.; Nowalk, Mary Patricia; Raviotta, Jonathan M.; Jackson, Michael L.; Jackson, Lisa; Ohmit, Suzanne E.; Petrie, Joshua G.; Monto, Arnold S.; Meece, Jennifer K.; Thaker, Swathi N.; Clippard, Jessie R.; Spencer, Sarah M.; Fry, Alicia M.; Belongia, Edward A.;
    Published:
    Nov 18 2014
    Source:
    J Infect Dis. 2014; 211(10):1529-1540.
    Description:
    During the 2012-2013 influenza season, there was cocirculation of influenza A(H3N2) and 2 influenza B lineage viruses in the United States.|Patients with acute cough illness for ≤7 days were prospectively enrolled and had swab samples obtained at o...
    File Type:
    Filetype[PDF - 396.12 KB]
  3. Influenza Vaccine Effectiveness in Older Adults Compared with Younger Adults Over Five Seasons
    Personal Author:
    Russell, Kate; Chung, Jessie R.; Monto, Arnold S.; Martin, Emily T.; Belongia, Edward A.; McLean, Huong Q.; Gaglani, Manjusha; Murthy, Kempapura; Zimmerman, Richard K.; Nowalk, Mary Patricia; Jackson, Michael L.; Jackson, Lisa A.; Flannery, Brendan;
    Published:
    Feb 28 2018
    Source:
    Vaccine. 36(10):1272-1278
    Description:
    Background : There have been inconsistent reports of decreased vaccine effectiveness (VE) against influenza viruses among older adults (aged ≥65 years) compared with younger adults in the United States. A direct comparison of VE over multiple seaso...
    File Type:
    Filetype[PDF - 147.25 KB]
  4. Burden of medically attended influenza infection and cases averted by vaccination — United States, 2013/14 through 2015/16 influenza seasons
    Personal Author:
    Jackson, Michael L.; Phillips, C. Hallie; Benoit, Joyce; Jackson, Lisa A.; Gaglani, Manjusha; Murthy, Kempapura; McLean, Huong Q.; Belongia, Edward A.; Malosh, Ryan; Zimmerman, Richard; Flannery, Brendan;
    Published:
    Dec 14 2017
    Source:
    Vaccine. 36(4):467-472.
    Description:
    Background : In addition to preventing hospitalizations and deaths due to influenza, influenza vaccination programs can reduce the burden of outpatient visits for influenza. We estimated the incidence of medically-attended influenza at three geograph...
    File Type:
    Filetype[PDF - 284.75 KB]
  5. Hospitalizations within 14 days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010–2012
    Personal Author:
    Millman, Alexander J.; Reynolds, Sue; Duffy, Jonathan; Chen, Jufu; Gargiullo, Paul; Fry, Alicia M.;
    Published:
    Dec 29 2016
    Source:
    Vaccine. 35(4):529-535.
    Description:
    Background : Live attenuated influenza vaccine (LAIV) is safe in healthy children ⩾2 years. The original clinical trials excluded individuals with underlying conditions; however, post-marketing data suggest LAIV may be safe for these populations. :...
    File Type:
    Filetype[PDF - 384.63 KB]